129 related articles for article (PubMed ID: 21501649)
1. Antithrombotic and profibrinolytic activities of phloroglucinol.
Bae JS
Food Chem Toxicol; 2011 Jul; 49(7):1572-7. PubMed ID: 21501649
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic and profibrinolytic activities of isorhamnetin-3-O-galactoside and hyperoside.
Ku SK; Kim TH; Lee S; Kim SM; Bae JS
Food Chem Toxicol; 2013 Mar; 53():197-204. PubMed ID: 23220618
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic and profibrinolytic activities of eckol and dieckol.
Kim TH; Ku SK; Bae JS
J Cell Biochem; 2012 Sep; 113(9):2877-83. PubMed ID: 22511271
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic activities of oroxylin A in vitro and in vivo.
Ku SK; Lee IC; Bae JS
Arch Pharm Res; 2014 May; 37(5):679-86. PubMed ID: 23963976
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic activities of pellitorine in vitro and in vivo.
Ku SK; Lee IC; Kim JA; Bae JS
Fitoterapia; 2013 Dec; 91():1-8. PubMed ID: 23973654
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.
Yoo H; Ku SK; Lee W; Kwak S; Baek YD; Min BW; Jeong GS; Bae JS
Arch Pharm Res; 2014 Aug; 37(8):1069-78. PubMed ID: 24234914
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa.
Ku SK; Lee W; Kang M; Bae JS
Arch Pharm Res; 2015 Jun; 38(6):1080-9. PubMed ID: 25325928
[TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells.
Zhou Z; Liu Y; Miao AD; Wang SQ
J Cell Biochem; 2005 Sep; 96(1):109-16. PubMed ID: 16052513
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo.
Ku SK; Bae JS
BMB Rep; 2014 Jul; 47(7):376-81. PubMed ID: 24286332
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa.
Ku SK; Bae JS
Arch Pharm Res; 2014 Nov; 37(11):1454-63. PubMed ID: 24817443
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant activities of piperlonguminine in vitro and in vivo.
Lee W; Yoo H; Ku SK; Kim JA; Bae JS
BMB Rep; 2013 Oct; 46(10):484-9. PubMed ID: 24148768
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant activities of persicarin and isorhamnetin.
Ku SK; Kim TH; Bae JS
Vascul Pharmacol; 2013 Apr; 58(4):272-9. PubMed ID: 23391847
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic activities of epi-sesamin in vitro and in vivo.
Ku SK; Kim JA; Han CK; Bae JS
Am J Chin Med; 2013; 41(6):1313-27. PubMed ID: 24228603
[TBL] [Abstract][Full Text] [Related]
15. Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-α-stimulated endothelial cells via the NF-κB/JNK/p38 MAPK signaling pathway.
Zheng X; Liu H; Ma M; Ji J; Zhu F; Sun L
Arch Pharm Res; 2021 Apr; 44(4):427-438. PubMed ID: 33847919
[TBL] [Abstract][Full Text] [Related]
16. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
Jiang R; Wang NP; Tanaka KA; Levy JH; Guyton RA; Zhao ZQ; Vinten-Johansen J
J Surg Res; 2011 Aug; 169(2):319-27. PubMed ID: 20451919
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.
Lee W; Ku SK; Bae JS
Arch Pharm Res; 2015; 38(5):893-903. PubMed ID: 24849036
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet, anticoagulant, and profibrinolytic activities of withaferin A.
Ku SK; Bae JS
Vascul Pharmacol; 2014 Mar; 60(3):120-6. PubMed ID: 24534482
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic activities of wogonin and wogonoside via inhibiting platelet aggregation.
Ku SK; Bae JS
Fitoterapia; 2014 Oct; 98():27-35. PubMed ID: 25020199
[TBL] [Abstract][Full Text] [Related]
20. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.
He CL; Yi PF; Fan QJ; Shen HQ; Jiang XL; Qin QQ; Song Z; Zhang C; Wu SC; Wei XB; Li YL; Fu BD
Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):215-24. PubMed ID: 23171279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
